Skip to main content
Top
Published in: European Journal of Nutrition 1/2018

01-02-2018 | Original Contribution

Identification of urinary metabolites with potential blood pressure-lowering effects in lentil-fed spontaneously hypertensive rats

Authors: Matthew Hanson, Peter Zahradka, Carla G. Taylor, Michel Aliani

Published in: European Journal of Nutrition | Issue 1/2018

Login to get access

Abstract

Purpose

Urine samples were obtained from a previously completed study that showed lentil consumption attenuates the increase in blood pressure that occurs over time in spontaneously hypertensive rats (SHRs). The objective of the present study was to compare the metabolite profile of the urine samples from control and lentil-fed SHR in relation to the compounds present in lentils but not in other pulses.

Methods

The urine samples were from 17-week-old, male SHR fed semi-purified diet prepared with powder (30 %, w/w) from cooked whole pulses or a pulse-free control diet (n = 8/group) for 4 weeks. Pulse powders, control diet and urine samples were extracted using acetonitrile and analyzed by a high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).

Results

Twenty-seven metabolites were significantly different in urine samples from lentil-fed SHR compared to SHR fed control diet, but only 7 were not present in the urine of SHR fed other pulses. Of these metabolites, only citrulline is linked to blood pressure regulation via production of the vasodilator nitric oxide (NO). Several arginine-related compounds that are NO synthase substrates or inhibitors were detected in lentils but not the control diet or other pulse powders.

Conclusions

Consumption of lentils increases the availability of arginine and several related compounds that could potentially elevate production of NO and contribute to the blood pressure-lowering effects of lentil-rich diets.
Appendix
Available only for authorised users
Literature
2.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252CrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252CrossRef
4.
go back to reference Curran J (2012) The nutritional value and health benefits of pulses in relation to obesity, diabetes, heart disease and cancer. Br J Nutr 108:S1–S2CrossRef Curran J (2012) The nutritional value and health benefits of pulses in relation to obesity, diabetes, heart disease and cancer. Br J Nutr 108:S1–S2CrossRef
6.
go back to reference Jayalath VH, de Souza RJ, Sievenpiper JL, Ha V, Chiavaroli L, Mirrahimi A, Di Buono M, Bernstein AM, Leiter LA, Kris-Etherton PM, Vuksan V, Beyene J, Kendall CW, Jenkins DJ (2014) Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens 27:56–64. doi:10.1093/ajh/hpt155 CrossRef Jayalath VH, de Souza RJ, Sievenpiper JL, Ha V, Chiavaroli L, Mirrahimi A, Di Buono M, Bernstein AM, Leiter LA, Kris-Etherton PM, Vuksan V, Beyene J, Kendall CW, Jenkins DJ (2014) Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens 27:56–64. doi:10.​1093/​ajh/​hpt155 CrossRef
7.
go back to reference Mukai Y, Sato S (2009) Polyphenol-containing azuki bean (Vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension. Nutr Metab Cardiovasc Dis 19:491–497CrossRef Mukai Y, Sato S (2009) Polyphenol-containing azuki bean (Vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension. Nutr Metab Cardiovasc Dis 19:491–497CrossRef
9.
go back to reference Akira K, Masu S, Imachi M, Mitome H, Hashimoto T (2012) A metabonomic study of biochemical changes characteristic of genetically hypertensive rats based on 1H NMR spectroscopic urinalysis. Hypertens Res 35:404–412CrossRef Akira K, Masu S, Imachi M, Mitome H, Hashimoto T (2012) A metabonomic study of biochemical changes characteristic of genetically hypertensive rats based on 1H NMR spectroscopic urinalysis. Hypertens Res 35:404–412CrossRef
10.
go back to reference Onuh JO, Girgih AT, Ievari-Shariati S, Malomo SA, Aluko RE, Aliani M (2015) Kinetics of in vitro renin and angiotensin converting enzyme inhibition by chicken skin protein hydrolysates and their blood pressure lowering effects in spontaneously hypertensive rats. J Funct Foods 14:133–143. doi:10.1016/j.jff.2015.01.031 CrossRef Onuh JO, Girgih AT, Ievari-Shariati S, Malomo SA, Aluko RE, Aliani M (2015) Kinetics of in vitro renin and angiotensin converting enzyme inhibition by chicken skin protein hydrolysates and their blood pressure lowering effects in spontaneously hypertensive rats. J Funct Foods 14:133–143. doi:10.​1016/​j.​jff.​2015.​01.​031 CrossRef
11.
go back to reference Grant J, Whitehurst K, Taylor CG, Zahradka P, Aliani M (2015) Urinary metabolomics profile of genetically obese rats using liquid chromatography quadrupole time-of-flight mass spectrometry. Jacobs J Biomark 1:015 Grant J, Whitehurst K, Taylor CG, Zahradka P, Aliani M (2015) Urinary metabolomics profile of genetically obese rats using liquid chromatography quadrupole time-of-flight mass spectrometry. Jacobs J Biomark 1:015
12.
go back to reference Iwaniak A, Minkiewicz P, Darewicz M (2014) Food-originating ACE inhibitors, including antihypertensive peptides, as preventive food components in blood pressure reduction. Compr Rev Food Sci Food Saf 13:114–134CrossRef Iwaniak A, Minkiewicz P, Darewicz M (2014) Food-originating ACE inhibitors, including antihypertensive peptides, as preventive food components in blood pressure reduction. Compr Rev Food Sci Food Saf 13:114–134CrossRef
13.
go back to reference Xie J, Pierce JG, James RC, Okano A, Boger DL (2011) A redesigned Vancomycin engineered for dual D-Ala-D-Ala and D-Ala-D-Lac binding exhibits potent antimicrobial activity against Vancomycin-resistant bacteria. J Am Chem Soc 133:13946–13949CrossRef Xie J, Pierce JG, James RC, Okano A, Boger DL (2011) A redesigned Vancomycin engineered for dual D-Ala-D-Ala and D-Ala-D-Lac binding exhibits potent antimicrobial activity against Vancomycin-resistant bacteria. J Am Chem Soc 133:13946–13949CrossRef
14.
go back to reference Lal KJ, Dakshinamurti K, Thliveris J (1996) The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. J Hypertens 14:355–363CrossRef Lal KJ, Dakshinamurti K, Thliveris J (1996) The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. J Hypertens 14:355–363CrossRef
15.
go back to reference McMahon JA, Skeaff CM, Williams SM, Green TJ (2007) Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J Nutr 137:1183–1187CrossRef McMahon JA, Skeaff CM, Williams SM, Green TJ (2007) Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J Nutr 137:1183–1187CrossRef
16.
go back to reference Chang YO (1965) Excretion of total nitrogen, lysine and methionine by rats as affected by the type of carbohydrate in the diet. J Nutr 85:207–212CrossRef Chang YO (1965) Excretion of total nitrogen, lysine and methionine by rats as affected by the type of carbohydrate in the diet. J Nutr 85:207–212CrossRef
17.
go back to reference Semba RD, Sun K, Schwartz AV, Varadhan R, Harris TB, Satterfield S, Garcia M, Ferrucci L, Newman AB, Health ABCS (2015) Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults. J Hypertens 33:797–803. doi:10.1097/HJH.0000000000000460 (discussion 803) CrossRef Semba RD, Sun K, Schwartz AV, Varadhan R, Harris TB, Satterfield S, Garcia M, Ferrucci L, Newman AB, Health ABCS (2015) Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults. J Hypertens 33:797–803. doi:10.​1097/​HJH.​0000000000000460​ (discussion 803) CrossRef
19.
go back to reference van de Poll MCG, Siroen MPC, van Leeuwen PAM, Soeters PB, Melis GC, Boelens PG, Deutz NEP, Dejong CHC (2007) Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am J Clin Nutr 85:167–172CrossRef van de Poll MCG, Siroen MPC, van Leeuwen PAM, Soeters PB, Melis GC, Boelens PG, Deutz NEP, Dejong CHC (2007) Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am J Clin Nutr 85:167–172CrossRef
20.
go back to reference Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G (2006) l-arginine therapy in acute myocardial infarction - The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. Jama-J Am Med Assoc 295:58–64. doi:10.1001/jama.295.1.58 CrossRef Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G (2006) l-arginine therapy in acute myocardial infarction - The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. Jama-J Am Med Assoc 295:58–64. doi:10.​1001/​jama.​295.​1.​58 CrossRef
22.
go back to reference van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouwer CD, Teerlink T (2013) L-Homoarginine and l-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 6:1114–1123CrossRef van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouwer CD, Teerlink T (2013) L-Homoarginine and l-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 6:1114–1123CrossRef
24.
go back to reference Angulo J, Cuevas P, Fernandez A, Gabancho S, Allona A, Martin-Morales A, Moncada I, de Tejada IS (2003) Activation and potentiation of the NO/cGMP pathway by N-G-hydroxyl-l-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing. Br J Pharmacol 138:63–70. doi:10.1038/sj.bjp.0705027 CrossRef Angulo J, Cuevas P, Fernandez A, Gabancho S, Allona A, Martin-Morales A, Moncada I, de Tejada IS (2003) Activation and potentiation of the NO/cGMP pathway by N-G-hydroxyl-l-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing. Br J Pharmacol 138:63–70. doi:10.​1038/​sj.​bjp.​0705027 CrossRef
25.
go back to reference Korth HG, Sustmann R, Thater C, Butler AR, Ingold KU (1994) on the mechanism of the nitric-oxide synthase-catalyzed conversion of N-omega-hydroxy-l-arginine to citrulline and nitric-oxide. J Biol Chem 269:17776–17779 Korth HG, Sustmann R, Thater C, Butler AR, Ingold KU (1994) on the mechanism of the nitric-oxide synthase-catalyzed conversion of N-omega-hydroxy-l-arginine to citrulline and nitric-oxide. J Biol Chem 269:17776–17779
26.
go back to reference Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D (1998) Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N-omega-hydroxy derivatives, and N-omega-hydroxynor-l-arginine. Biochemistry 37:10453–10460. doi:10.1021/bi980742t CrossRef Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D (1998) Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N-omega-hydroxy derivatives, and N-omega-hydroxynor-l-arginine. Biochemistry 37:10453–10460. doi:10.​1021/​bi980742t CrossRef
27.
go back to reference Vetrovsky P, Boucher JL, Schott C, Beranova P, Chalupsky K, Callizot N, Muller B, Entlicher G, Mansuy D, Stoclet JC (2002) Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-l-arginine and other compounds bearing a C = NOH function in the rat aorta. J Pharmacol Exp Ther 303:823–830. doi:10.1124/jpet.102.038612 CrossRef Vetrovsky P, Boucher JL, Schott C, Beranova P, Chalupsky K, Callizot N, Muller B, Entlicher G, Mansuy D, Stoclet JC (2002) Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-l-arginine and other compounds bearing a C = NOH function in the rat aorta. J Pharmacol Exp Ther 303:823–830. doi:10.​1124/​jpet.​102.​038612 CrossRef
28.
go back to reference Xuan CL, Yao FR, Guo LR, Liu Q, Chang SK, Liu KX, Sun CW (2013) Comparison of extracts from cooked and raw lentil in antagonizing angiotensin II-induced hypertension and cardiac hypertrophy. Eur Rev Med Pharmacol Sci 17:2644–2653 Xuan CL, Yao FR, Guo LR, Liu Q, Chang SK, Liu KX, Sun CW (2013) Comparison of extracts from cooked and raw lentil in antagonizing angiotensin II-induced hypertension and cardiac hypertrophy. Eur Rev Med Pharmacol Sci 17:2644–2653
29.
go back to reference Yao FR, Sun CW, Chang SKC (2012) Lentil polyphenol extract prevents angiotensin II-induced hypertension, vascular remodelling and perivascular fibrosis. Food Funct 3:127–133. doi:10.1039/C1fo10142k CrossRef Yao FR, Sun CW, Chang SKC (2012) Lentil polyphenol extract prevents angiotensin II-induced hypertension, vascular remodelling and perivascular fibrosis. Food Funct 3:127–133. doi:10.​1039/​C1fo10142k CrossRef
Metadata
Title
Identification of urinary metabolites with potential blood pressure-lowering effects in lentil-fed spontaneously hypertensive rats
Authors
Matthew Hanson
Peter Zahradka
Carla G. Taylor
Michel Aliani
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 1/2018
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1319-5

Other articles of this Issue 1/2018

European Journal of Nutrition 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.